Versant Venture Management

Versant Venture Management as of Sept. 30, 2019

Portfolio Holdings for Versant Venture Management

Versant Venture Management holds 8 positions in its portfolio as reported in the September 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Crispr Therapeutics (CRSP) 67.2 $174M 4.2M 40.99
Veracyte (VCYT) 11.2 $29M 1.2M 24.00
Gritstone Oncology Ord (GRTS) 10.4 $27M 3.1M 8.63
Audentes Therapeutics 6.0 $16M 554k 28.09
Ocular Therapeutix (OCUL) 2.6 $6.7M 2.2M 3.04
Second Sight Med Prods 1.4 $3.7M 4.5M 0.82
Cymabay Therapeutics (CBAY) 1.1 $2.8M 544k 5.12
Clovis Oncology 0.1 $400k 102k 3.93